These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25918954)

  • 1. Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy.
    Rapti E; Gazouli M; Legaki E; Karamanolis G; Thomas D; Marinos E; Papaconstantinou I
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):339-43. PubMed ID: 25918954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease.
    Ebrahimi Daryani N; Saghazadeh A; Moossavi S; Sadr M; Shahkarami S; Soltani S; Farhadi E; Rezaei N
    Immunol Invest; 2017 Oct; 46(7):714-729. PubMed ID: 28872970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma.
    Yang X; Xiong G; Chen X; Xu X; Wang K; Fu Y; Yang K; Bai Y
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1341-9. PubMed ID: 19352701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis.
    Zou L; Wang L; Gong X; Zhao H; Jiang A; Zheng S
    Autoimmunity; 2014 Feb; 47(1):27-39. PubMed ID: 24128120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
    Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms.
    Repnik K; Potocnik U
    DNA Cell Biol; 2010 Oct; 29(10):603-10. PubMed ID: 20491567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of
    Kafadar D; Yaylim I; Kafadar AM; Cacina C; Ergen A; Kaynar MY; Isbir T
    Anticancer Res; 2018 Oct; 38(10):5991-5998. PubMed ID: 30275230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
    Yamak N; Yaykasli KO; Yilmaz U; Eroz R; Uzunlar AK; Ankarali H; Sahiner C; Baltaci D
    Asian Pac J Cancer Prev; 2014; 15(20):8963-7. PubMed ID: 25374237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
    Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the-801G/A polymorphism of CXCL12 gene with the risk of inflammatory bowel diseases development in a Polish population.
    Mrowicki J; Przybyłowska K; Dziki L; Sygut A; Wiśniewska-Jarosińska M; Chojnacki J; Dziki A; Majsterek I
    Pol Przegl Chir; 2011 Jun; 83(6):334-8. PubMed ID: 22166550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.
    Eloranta JJ; Wenger C; Mwinyi J; Hiller C; Gubler C; Vavricka SR; Fried M; Kullak-Ublick GA;
    Pharmacogenet Genomics; 2011 Sep; 21(9):559-64. PubMed ID: 21832969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Bossa F; Latiano T; Devoto M; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1129-38. PubMed ID: 16305727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease.
    Bjerrum JT; Steenholdt C; Ainsworth M; Nielsen OH; Reed MA; Atkins K; Günther UL; Hao F; Wang Y
    BMC Med; 2017 Oct; 15(1):184. PubMed ID: 29032767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
    Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
    Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
    Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
    Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
    Cheng ZJ; Hu LH; Huang SJ
    Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.
    Yoon SM; Haritunians T; Chhina S; Liu Z; Yang S; Landers C; Li D; Ye BD; Shih D; Vasiliauskas EA; Ippoliti A; Rabizadeh S; Targan SR; Melmed GY; McGovern DPB
    Inflamm Bowel Dis; 2017 Aug; 23(8):1382-1393. PubMed ID: 28590340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.